Analysis of the Mechanisms That Underlie Absorption of Botulinum Toxin by the Inhalation Route
Open Access
- 1 December 2012
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 80 (12), 4133-4142
- https://doi.org/10.1128/iai.00669-12
Abstract
Botulinum toxin is a highly potent oral and inhalation poison, which means that the toxin must have an efficient mechanism for penetration of epithelial barriers. To date, three models for toxin passage across epithelial barriers have been proposed: (i) the toxin itself undergoes binding and transcytosis; (ii) an auxiliary protein, HA35, transports toxin from the apical to the basal side of epithelial cells; and (iii) an auxiliary protein, HA35, acts on the basal side of epithelial cells to disrupt tight junctions, and this permits paracellular flux of toxin. These models were evaluated by studying toxin absorption following inhalation exposure in mice. Three types of experiments were conducted. In the first, the potency of pure neurotoxin was compared with that of progenitor toxin complex, which contains HA35. The results showed that the rate and extent of toxin absorption, as well as the potency of absorbed toxin, did not depend upon, nor were they enhanced by, the presence of HA35. In the second type of experiment, the potencies of pure neurotoxin and progenitor toxin complex were compared in the absence or presence of antibodies on the apical side of epithelial cells. Antibodies directed against the neurotoxin protected against challenge, but antibodies against HA35 did not. In the final type of experiment, the potency of pure neurotoxin and toxin complex was compared in animals pretreated to deliver antibodies to the basal side of epithelial cells. Once again, antibodies directed against the neurotoxin provided resistance to challenge, but antibodies directed against HA35 did not. Taken collectively, the data indicate that the toxin by itself is capable of crossing epithelial barriers. The data do not support any hypothesis in which HA35 is essential for toxin penetration of epithelial barriers.Keywords
This publication has 36 references indexed in Scilit:
- Modulation of botulinum toxin-induced changes in neuromuscular function with antibodies directed against recombinant polypeptides or fragmentsNeuroscience, 2011
- Disruption of the epithelial barrier by botulinum haemagglutinin (HA) proteins – differences in cell tropism and the mechanism of action between HA proteins of types A or B, and HA proteins of type CMicrobiology, 2009
- Botulinum ToxinPublished by Elsevier BV ,2009
- The Role of Systemic Handling in the Pathophysiologic Actions of Botulinum ToxinThe Journal of pharmacology and experimental therapeutics, 2008
- The HA proteins of botulinum toxin disrupt intestinal epithelial intercellular junctions to increase toxin absorptionCellular Microbiology, 2007
- Wound Botulism in Injection Drug UsersEmerging Infectious Diseases, 2007
- Trivalent Vaccine against Botulinum Toxin Serotypes A, B, and E That Can Be Administered by the Mucosal RouteInfection and Immunity, 2007
- Transport of Bacterial Toxins into Target Cells: Pathways Followed by Cholera Toxin and Botulinum Progenitor ToxinThe Journal of Biochemistry, 2006
- Wound Botulism in California, 1951–1998: Recent Epidemic in Heroin InjectorsClinical Infectious Diseases, 2000
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970